Napp announces acceptance of Rezafungin Marketing Authorisation Application
16 Nov 2022 //
BUSINESSWIRE
Napp Pharmaceuticals Announces European Commission Approval of Invokana®
02 Jul 2020 //
BUSINESSWIRE
Napp Announces European Commission Approval of Invokana® (canagliflozin)
01 Jul 2020 //
BUSINESSWIRE